market-trends is the sole category represented across all 1 tracked stories. Medical Aesthetics is most often covered alongside Intraocular Lenses, which appears in 1 of these 1 story. Each story carries 2 original sources on average, compared with 3.6 for the broader beat in this window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Medical Aesthetics
market-trends is the sole category represented across all 1 tracked stories. Medical Aesthetics is most often covered alongside Intraocular Lenses, which appears in 1 of these 1 story. Each story carries 2 original sources on average, compared with 3.6 for the broader beat in this window. The 5 average consequence score is below the beat benchmark of 5.9 in the same window. We currently track 1 Healthcare story that mention Medical Aesthetics, all published on March 21, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 20 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Medical Aesthetics. Shared-story counts are live from our verified record — not editorial picks.
Shanghai Haohai Biological Technology Co., Ltd. has reported a retreat in its full-year net income, reflecting the intensifying impact of China's centralized procurement policies. The decline underscores the challenges facing domestic medtech leaders as they navigate margin compression in ophthalmology and heightened competition in the medical aesthetics market.